The multi-billion-dollar bid could further cement AbbVie’s leading position in the immunology space as competition heats up.
US manufacturers defy the tragedy of the commons by jointly sponsoring efforts to attract new talent amid onshoring.
BioArctic will create a new drug candidate using its BrainTransporter platform and Lilly’s molecule.
If investigators uncover violations, this could enable the USTR to pursue unilateral action against Germany.
Reqorsa is currently in development alongside approved cancer drugs.
The panel unanimously said that the benefits of Moderna's mRNA jab outweigh its risks in preventing influenza in certain age groups.
